Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

3.4K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
3.4K
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

836
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
836

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and clinical application of a primary cancer organoid-PBMC co-culture system for personalized immunotherapy.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same author

Inhibition of ferroptosis via SLC25A39-NRF2 axis drives Osimertinib resistance in lung adenocarcinoma.

Cellular and molecular life sciences : CMLS·2026
Same author

Fully-connected microwave photonic multi-beamformer with fast beam-steering for broadband wireless communication.

Nature communications·2026
Same author

TELO2-interacting protein 1 (TTI1), a novel Wnt/β-catenin target gene, decreases chemo-sensitivity in colorectal cancer by modulating DNA damage responses.

Molecular biomedicine·2026
Same author

Constructing a biomimetic ECM protective barrier: a strategic interface design for urethral repair to mitigate foreign body reaction.

Journal of nanobiotechnology·2026
Same author

Janus Calix[6]Arene Dual-Site Additive Enables Dendrite-Free Aqueous Zn Batteries.

Small (Weinheim an der Bergstrasse, Germany)·2026

Related Experiment Video

Updated: May 1, 2026

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.3K

Molecular diagnostics on lymphoid malignancies.

Wing C Chan1, Kai Fu

  • 1Department of Pathology/Microbiology, University of Nebraska Medical Center, Omaha 68198-3135, USA. jchan@unmc.edu

Archives of Pathology & Laboratory Medicine
|December 8, 2004
PubMed
Summary
This summary is machine-generated.

Molecular diagnostics for lymphoid malignancies have evolved beyond initial diagnosis. Advances now enable monitoring disease activity and identifying genetic alterations for personalized, mechanism-based therapies.

More Related Videos

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

19.7K
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.8K

Related Experiment Videos

Last Updated: May 1, 2026

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.3K
Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

19.7K
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.8K

Area of Science:

  • Hematology
  • Oncology
  • Genomics

Background:

  • Molecular diagnostics traditionally focused on diagnosing lymphoid malignancies from tissue samples.
  • The field has evolved significantly over 20 years, expanding to disease monitoring and identifying impactful genetic alterations.

Purpose of the Study:

  • To review advances in molecular diagnostics for lymphoid malignancies.
  • To highlight recent developments enabling mechanism-based diagnosis for individualized therapy.

Main Methods:

  • Review of molecular diagnostic development in lymphoid malignancies.
  • Emphasis on gene expression profiling for diagnostic and prognostic signatures.

Main Results:

  • Genome-scale investigations are feasible and identify new disease entities and prognosticators.
  • Molecular diagnostics will provide crucial information for guiding therapy.
  • Future diagnostics aim to deliver the most appropriate treatment with minimal toxicity.

Conclusions:

  • Molecular diagnostics in lymphoid malignancies are shifting towards mechanism-based diagnosis.
  • This shift supports the development of individualized therapeutic strategies.